[Pharmacological and clinical profile of imidafenacin developed as a new therapeutic agent for overactive bladder].
Uno
Takashi
T
Kobayashi
Fumiyoshi
F
Ogata
Akihito
A
Konomi
Toshihiko
T
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D004558:Electric Stimulation; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D011788:Quality of Life; D011976:Receptors, Muscarinic; D001743:Urinary Bladder / Q000378:metabolism; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014554:Urination / Q000187:drug effects
D007093:Imidazoles; D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D002217:Carbachol; D000109:Acetylcholine; C120953:imidafenacin